Nagasaki schizophrenia study: Relationship between ultralong-term outcome(after 28 years)and duration of untreated psychosis

Acta Medica Nagasakiensia

Volumn 54, Issue 3, 2010, Pages 59-66

  Ichinose, Hitoshi ^a   Nakane, Yoshibumi ^b   Nakane, Hideyuki ^a   Kinoshita, Hirohisa ^c   Ohta, Yasuyuki ^d   Honda, Sumihisa ^a   Ozawa, Hiroki ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b Department of Neuropsychiatry   (Japan)

^c NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^d NISHIKYUSHU UNIVERSITY   (Japan)

Author keywords

Duration of untreated psychosis; Schizophrenia; Ultralong term outcome

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONDUCT DISORDER; CONTROLLED STUDY; DISEASE DURATION; EMOTIONAL DISORDER; FEMALE; FOLLOW UP; HEBEPHRENIA; HUMAN; MALE; PARANOID SCHIZOPHRENIA; PROGNOSIS; SCHIZOPHRENIA; SOCIAL ADAPTATION;

EID: 77950397245     PISSN: 00016055     EISSN: 00016055     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T.: Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry Sep 62(9): 975-983, 2005
2. Loebel AD, Lieberman JA, Alvir JM, et al. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 149: 1183-1188, 1992
3. Perkins DO. Review: Longer duration of untreated psychosis is associated with worse outcome in people with first episode psychosis. Evid Based Ment Health 9(2): 36, 2006
4. Perkins DO, Gu H, Boteva K, Lieberman JA.: Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 162(10): 1785-1804, 2005
5. Farooq S, Large M, Nielssen O, Waheed W. The relationship between the duration of untreated psychosis and outcome in low-and-middle income countries: A systematic review and meta analysis. Shizophr Res 109; 15-23, 2009
6. Larsen TK, McGlashan TH, Moe LC. First-episode schizophrenia: I. Early course parameters. Shizophr Bull 22(2): 241-256, 1996
7. Harrigan SM, McGorry PD, Krstev H. Does treatment delay in first-episode psychosis really matter? Psychol Med 33(1):97-110.2003
8. Drake RJ, Haley CJ, Akhtar S, Lewis SW. Causes and consequences of duration of untreated psychosis in schizophrenia. Br J Psychiatry 177: 511-515, 2000
9. Black K, Peters L, Rui Q, Milliken H, Whitehorn D, Kopala LC. Duration of untreated psychosis predicts treatment outcome in an early psychosis program. Schizophr Res 47: 215-222, 2001
10. Szymanski SR, Cannon TD, Gallacher F, Erwin RJ, Gur RE. Course of treatment response in first-episode and chronic schizophrenia. Am J Psychiatry 153: 519-525,1996
11. Uçok A, Polat A, Genc A, Turan N.. Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia. J Psychiatr Res 38: 163-168,2004
12. Wunderink A, Nienhuis FJ, Sytema S, Wiersma D. Treatment delay and response rate in first episode psychosis. Acta Psychiatr Scand 113(4): 332-9, 2006.
13. Fuchs J, Steinert T. Dauer der unbehandelten psychose (DUP): ein brauchbarer pradiktor fur den krankheitsverlauf? [Duration of untreated psychosis (DUP):An useful predictor of outcome in schizophrenia?] Fortschr Neurol Psychiatr 72: 79-87,2004
14. Yamazawa R, Mizuno M, Nemoto T, Miura Y, Murakami M, Kashima H. Duration of untreated psychosis and pathways to psychiatric services in first-episode schizophrenia. Psychiatry Clin Neurosci 58: 76-81, 2004
15. Yamazawa R, Nemoto T, Kobayashi H, Chino B, Kashima H, Mizuno M. Association between duration of untreated psychosis, premorbid functioning, and cognitive performance and the outcome of first-episode schizophrenia in Japanese patients: prospective study. Aust N Z J Psychiatry 42: 159-165, 2008
16. Ucok A, Polat A, Cakir S, Genc A. One year outcome in first episode schizophrenia. Predictors of relapse. Eur Arch Psychiatry Clin Neurosci 256(1): 37-43, Epub 2005 Jul 18.2006
17. Larsen TK, Moe LC, Vibe-Hansen L, Johannessen JO. Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Shizophr Res 45: 1-9, 2000
18. Malla AK, Norman RM, Manchanda R, et al. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res 54: 231-242, 2002
19. Barnes TRE, Leeson VC, Mutsatsa SH, Watt HC, Hutton SB, Joyce EM. Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia. Br J Psychiatry 193: 203-209, 2008
20. Perkins DO, Lieberman JA, Gu H,et al. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry 185: 18-24, 2004
21. Oosthuizen P, Emsley RA, Keyter N, Niehaus DJ, Koen L. Duration of untreated psychosis and outcome in first-episode psychosis. Perspective from a developing country. Acta Psychiatr Scand 111(3): 214-9, 2005
22. Schimmelmann BG, Huber CG, Lambert M, Cotton S, McGorry PD, Conus P. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. J Psychiatr Res 42: 982-990, 2008
23. Addington J, Vanmastrigt S, Addington D. Duration of untreated psychosis: impact on 2-year outcome. Psychol Med 34: 277-284, 2004
24. Keshavan MS, Haas G, Miewald J,et al. Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophr Bull 29(4): 757-769, 2003
25. Clarke M, Whitty P, Browne S, et al. Untreated illness and outcome of psychosis. Br J Psychiatry 189: 235-240, 2006
26. Altamura AC, Bassetti R, Sassella F, Salvadori D, Mundo E. Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study. Schizophr Res 52: 29-36, 2001
27. de Haan L, Linszen DH, Lenior ME, de Win ED, Gorsira R. Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication. Schizophr Bull 29(2): 341-8, 2003
28. Harris MG, Henry LP, Harrigan SM, et al. The relationship between duration of untreated psychosis and outcome: An eight-year prospective study. Schizophr Res 79: 85-93, 2005
29. Bottlender R, Sato T, Jäger M, et al. The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia. Schizophr Res 62: 37-44, 2003
30. Wiersma D, Nienhuis FJ, Slooff CJ, Giel R. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull 24(1): 75-85,1998
31. Kua J, Wong KE, Kua EH, Tsoi WF. A 20-year follow-up study on schizophrenia in Singapore. Acta Psychiatr Scand 108: 118-125, 2003
32. Larsen TK, McGlashan TH, Johannessen JO, et al. Shortened duration of untreated first episode of psychosis: changes in patient characteristics at treatment. Am J Psychiatry 158(11): 1917-9, 2001
33. Melle I, Larsen TK, Haahr U,et al. Reducing the duration of untreated first-episode psychosis. Effects on clinical presentation. Arch Gen Psychiatry 61: 143-150, 2004
34. Melle I, Larsen TK, Haahr U, et al.. Prevention of negative symptom psychopathologies in first-episode schizophrenia: Two-year effects of reducing the duration of untreated psychosis. Arch Gen Psychiatry 65(6): 634-640, 2008
35. Novak Sarotar B, Pesek MB, Agius M, Kocmur M. Duration of untreated psychosis and it's effect on the symptomatic recovery in schizophrenia - preliminary results. Neuro Endocrinol Lett. 29(6): 990-4. 2008
36. Nakane Y, Takada K, Yoshitake K, Hatada K. DOSMeD: Nagasaki, Japan. In Recovery from Schizophrenia: an international perspective. A report from the WHO collaborative project, the international study of schizophrenia (Hopper K, Harrison G, Janca A, Sartorius N eds.; Oxford University Press, Oxford) pp. 164-176, 2007
37. Nakane Y, Ohta Y & Radford MHB. Epidemiological Studies of schizophrenia in Japan. Schizophrenia Bulletin 18(1): 75-84, 1992
38. Jablensky A, Sartorius N, Ernberg G et al. Schizophrenia: Manifestations, Incidence and Course in Different Cultures: A World Health Organization Ten-country Study. Psychological Medicine Monograph, Suppl 20, Cambridge University Press, Cambridge, 1992
39. Kramer M, Sartorius N, Jablensky A, Gulbinat W. The ICD-9 classification of mental disorders: a review of its development and contents. Acta Psychiatr Scand 59: 241-262, 1979
40. The ICD-10 Classification of Mental and Behavioral Disorders: Clinical descriptions and diagnostic guidelines. World Health Organization, Geneva, 1992
41. Takada K, Yoshitake K, Nakane Y, et al. Nagasaki Schizophrenia Study: Outcome of a 15-year follow-up of an incident cohort. Acta Med Nagasaki 42: 39-44, 1997
42. Kinoshita H, Nakane Y, Nakane H, et al. Nagasaki Schizophrenia Study: Influence of the duration of untreated psychosis on long-term outcome. Acta Med Nagasaki 50: 17-22, 2005
43. WHO Psychiatric Disability Assessment Schedule (WHO/DAS), World Health Organization, Geneva, 1988
44. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The Global Assessment Scale. A pro cedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33: 766-771, 1976
45. Leon AC, Shear MK, Klerman GL. A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression. J Clin Psychopharmacol 13(5): 327-331, 1993
46. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Shizophr Bull 8(3): 470-484, 1982
47. Gupta S, Rajaprabhakaran R, Arndt S, Flaum M, Andreasen NC. Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia. Schizophr Res 16(3): 189-97, 1995
48. McGlashan TH. Duration of untreated psychosis in first-episode schizophrenia: Marker or determinant of course? Biol Psychiatry 46: 899-907, 1999
49. Wing, J.K.; Cooper, J.E.; and Sartorius, N. The Measurement and Classification of Psychiatric Symptoms. England: Cambridge University Press, Cambridge, 1974
50. WHO Life Chart Schedule (LCS), World Health Organization, Geneva, 1992
51. Keshavan MS, Haas GL, Kahn CE, et al. Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible? J Psychiatr Res 32(3-4): 161-167, 1998
52. Lappin JM, Morgan K, Morgan C, et al Gray matter abnormalities associated with duration of untreated psychosis. Schizophr Res 83: 145-153, 2006
53. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 8(6): 592-610, 2003